Search Results

Active Recovery TMS: Breakthrough Depression Treatment Transforms Lives.

• Authors : HURT, NATALIA

Subjects: ELECTROCONVULSIVE therapy; MENTAL depression; TRANSCRANIAL magnetic stimulation

• Source: Oregon Business Magazine. Apr2022, Vol. 45 Issue 4, p12-13. 2p.

Record details

Motif Neurotech successfully implants pea-sized 'brain pacemaker' for depression.

• Authors : Park, Andrea (AUTHOR)

Subjects: MENTAL depression; DEEP brain stimulation

• Source: FierceBiotech. 9/18/2023, pN.PAG-N.PAG. 1p.

Record details

Taking care of someone who suffers from depression.

Subjects: MENTAL depression; SUPPORT groups

• Source: Business Weekly (Knowledge Bylanes). 10/9/2023, pN.PAG-N.PAG. 1p.

Record details

Weekly Policy Papers.

Subjects: LEGISLATIVE libraries; ASSOCIATIONS, institutions, etc.; PUBLISHING

• Source: Education Parliamentary Monitor; 11/27/2023, Issue 1081, p1-3, 3p

Record details

Breaking the Cycle of Self-Sabotage: How to Overcome the "Golden Larva Syndrome".

• Authors : de Vries, Manfred F. R. Kets

Subjects: FINANCIAL services industry; BUTTERFLIES; MENTAL depression

• Source: INSEAD Knowledge Publications; May2023, p1-5, 5p, 1 Color Photograph

Record details

A mental health platform designed with Gen Z in mind.

• Authors : Place, Alyssa

Subjects: MENTAL health; MENTAL depression

• Source: Ebn.benefitsnews.com. 4/14/2023, pN.PAG-N.PAG. 1p.

Record details

A New Wave of Antidepressants.

• Authors : FAGAN, ABIGAIL

Subjects: ANTIDEPRESSANTS; MENTAL depression; DRUG approvalUNITED States. Food & Drug Administration

• Source: Psychology Today. Jul/Aug2019, Vol. 52 Issue 4, p19-19. 2/3p.

Record details

Forest submits NDA for treatment of major depressive disorder to FDA.

Subjects: *PHARMACEUTICAL industry; DRUG approval; MENTAL depressionUNITED StatesUNITED States. Food & Drug Administration

• Source: PharmaWatch: CNS. Nov2012, Vol. 11 Issue 11, p15-16. 2p.

Record details

Pfizer announces encouraging data from major depressive disorder study.

Subjects: MENTAL depression; THERAPEUTICS; DISEASE relapsePFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: PharmaWatch: CNS. Jul2012, Vol. 11 Issue 7, p23-25. 3p.

Record details

Forest Labs and Pierre report positive results from Phase III MDD trial.

Subjects: CLINICAL trials; MENTAL depression; THERAPEUTICSFOREST Laboratories Inc. FOREST Laboratories Inc. FOREST Laboratories Inc. FRX; PIERRE Fabre Medicament SA

• Source: PharmaWatch: CNS. Jun2012, Vol. 11 Issue 6, p24-25. 2p.

Record details